FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2511112097> ?p ?o ?g. }

• W2511112097 endingPage "e1002101" @default.
• W2511112097 startingPage "e1002101" @default.
• W2511112097 abstract "Little is known about how adverse events are summarised and reported in trials, as detailed information is usually considered confidential. We have acquired clinical study reports (CSRs) from the European Medicines Agency through the Freedom of Information Act. The CSRs describe the results of studies conducted as part of the application for marketing authorisation for the slimming pill orlistat. The purpose of this study was to study how adverse events were summarised and reported in study protocols, CSRs, and published papers of orlistat trials.We received the CSRs from seven randomised placebo controlled orlistat trials (4,225 participants) submitted by Roche. The CSRs consisted of 8,716 pages and included protocols. Two researchers independently extracted data on adverse events from protocols and CSRs. Corresponding published papers were identified on PubMed and adverse event data were extracted from this source as well. All three sources were compared. Individual adverse events from one trial were summed and compared to the totals in the summary report. None of the protocols or CSRs contained instructions for investigators on how to question participants about adverse events. In CSRs, gastrointestinal adverse events were only coded if the participant reported that they were bothersome, a condition that was not specified in the protocol for two of the trials. Serious adverse events were assessed for relationship to the drug by the sponsor, and all adverse events were coded by the sponsor using a glossary that could be updated by the sponsor. The criteria for withdrawal due to adverse events were in one case related to efficacy (high fasting glucose led to withdrawal), which meant that one trial had more withdrawals due to adverse events in the placebo group. Finally, only between 3% and 33% of the total number of investigator-reported adverse events from the trials were reported in the publications because of post hoc filters, though six of seven papers stated that all adverse events were recorded. For one trial, we identified an additional 1,318 adverse events that were not listed or mentioned in the CSR itself but could be identified through manually counting individual adverse events reported in an appendix. We discovered that the majority of patients had multiple episodes of the same adverse event that were only counted once, though this was not described in the CSRs. We also discovered that participants treated with orlistat experienced twice as many days with adverse events as participants treated with placebo (22.7 d versus 14.9 d, p-value < 0.0001, Student's t test). Furthermore, compared with the placebo group, adverse events in the orlistat group were more severe. None of this was stated in the CSR or in the published paper. Our analysis was restricted to one drug tested in the mid-1990s; our results might therefore not be applicable for newer drugs.In the orlistat trials, we identified important disparities in the reporting of adverse events between protocols, clinical study reports, and published papers. Reports of these trials seemed to have systematically understated adverse events. Based on these findings, systematic reviews of drugs might be improved by including protocols and CSRs in addition to published articles." @default.
• W2511112097 created "2016-09-16" @default.
• W2511112097 creator A5002375158 @default.
• W2511112097 creator A5022241752 @default.
• W2511112097 creator A5069219953 @default.
• W2511112097 date "2016-08-16" @default.
• W2511112097 modified "2023-10-15" @default.
• W2511112097 title "Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis" @default.
• W2511112097 cites W1607015646 @default.
• W2511112097 cites W1966406045 @default.
• W2511112097 cites W1970652218 @default.
• W2511112097 cites W1971423388 @default.
• W2511112097 cites W1974942855 @default.
• W2511112097 cites W1980641839 @default.
• W2511112097 cites W1984517734 @default.
• W2511112097 cites W1986360186 @default.
• W2511112097 cites W1987922225 @default.
• W2511112097 cites W1988187729 @default.
• W2511112097 cites W1990052409 @default.
• W2511112097 cites W1998613929 @default.
• W2511112097 cites W2008526478 @default.
• W2511112097 cites W2017076873 @default.
• W2511112097 cites W2023187985 @default.
• W2511112097 cites W2024233889 @default.
• W2511112097 cites W2030267313 @default.
• W2511112097 cites W2048083913 @default.
• W2511112097 cites W2060239739 @default.
• W2511112097 cites W2065002009 @default.
• W2511112097 cites W2079763503 @default.
• W2511112097 cites W2084421847 @default.
• W2511112097 cites W2104373595 @default.
• W2511112097 cites W2115759092 @default.
• W2511112097 cites W2132930967 @default.
• W2511112097 cites W2134860420 @default.
• W2511112097 cites W2139294235 @default.
• W2511112097 cites W2142225926 @default.
• W2511112097 cites W2142784237 @default.
• W2511112097 cites W2159238703 @default.
• W2511112097 cites W2161641220 @default.
• W2511112097 cites W2166266400 @default.
• W2511112097 cites W2168787182 @default.
• W2511112097 cites W4862497 @default.
• W2511112097 doi "https://doi.org/10.1371/journal.pmed.1002101" @default.
• W2511112097 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4987052" @default.
• W2511112097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27529343" @default.
• W2511112097 hasPublicationYear "2016" @default.
• W2511112097 type Work @default.
• W2511112097 sameAs 2511112097 @default.
• W2511112097 citedByCount "51" @default.
• W2511112097 countsByYear W25111120972016 @default.
• W2511112097 countsByYear W25111120972017 @default.
• W2511112097 countsByYear W25111120972018 @default.
• W2511112097 countsByYear W25111120972019 @default.
• W2511112097 countsByYear W25111120972020 @default.
• W2511112097 countsByYear W25111120972021 @default.
• W2511112097 countsByYear W25111120972022 @default.
• W2511112097 countsByYear W25111120972023 @default.
• W2511112097 crossrefType "journal-article" @default.
• W2511112097 hasAuthorship W2511112097A5002375158 @default.
• W2511112097 hasAuthorship W2511112097A5022241752 @default.
• W2511112097 hasAuthorship W2511112097A5069219953 @default.
• W2511112097 hasBestOaLocation W25111120971 @default.
• W2511112097 hasConcept C126322002 @default.
• W2511112097 hasConcept C142724271 @default.
• W2511112097 hasConcept C17744445 @default.
• W2511112097 hasConcept C197934379 @default.
• W2511112097 hasConcept C199475168 @default.
• W2511112097 hasConcept C199539241 @default.
• W2511112097 hasConcept C204787440 @default.
• W2511112097 hasConcept C2777105317 @default.
• W2511112097 hasConcept C2779473830 @default.
• W2511112097 hasConcept C2780385302 @default.
• W2511112097 hasConcept C2780780548 @default.
• W2511112097 hasConcept C511355011 @default.
• W2511112097 hasConcept C512399662 @default.
• W2511112097 hasConcept C535046627 @default.
• W2511112097 hasConcept C544821477 @default.
• W2511112097 hasConcept C57658597 @default.
• W2511112097 hasConcept C71924100 @default.
• W2511112097 hasConceptScore W2511112097C126322002 @default.
• W2511112097 hasConceptScore W2511112097C142724271 @default.
• W2511112097 hasConceptScore W2511112097C17744445 @default.
• W2511112097 hasConceptScore W2511112097C197934379 @default.
• W2511112097 hasConceptScore W2511112097C199475168 @default.
• W2511112097 hasConceptScore W2511112097C199539241 @default.
• W2511112097 hasConceptScore W2511112097C204787440 @default.
• W2511112097 hasConceptScore W2511112097C2777105317 @default.
• W2511112097 hasConceptScore W2511112097C2779473830 @default.
• W2511112097 hasConceptScore W2511112097C2780385302 @default.
• W2511112097 hasConceptScore W2511112097C2780780548 @default.
• W2511112097 hasConceptScore W2511112097C511355011 @default.
• W2511112097 hasConceptScore W2511112097C512399662 @default.
• W2511112097 hasConceptScore W2511112097C535046627 @default.
• W2511112097 hasConceptScore W2511112097C544821477 @default.
• W2511112097 hasConceptScore W2511112097C57658597 @default.
• W2511112097 hasConceptScore W2511112097C71924100 @default.
• W2511112097 hasIssue "8" @default.
• W2511112097 hasLocation W25111120971 @default.

• next